![]() Chaperone Therapeutics Chaperone Therapeutics is a company developing frontline therapies to address diseases of protein misfolding. | ![]() LTS Lohmann Therapie-Systeme LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances. | ||||
Founding Date | Founding Date 2009 | Founding Date 1901 | Founding Date 1984 | Founding Date 2018 | Founding Date N/A |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Durham, US HQ | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Andernach, DE HQ Shanghai, CN West Caldwell, US | Locations HK HQ | Locations CL HQ |
Employees | Employees 589% increase | Employees 37,000 | Employees 2991% increase | Employees 498 | Employees 1821% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥934.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $8.3b (FY, 2025) | Cost of goods N/A | Cost of goods ¥89.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $8.9b (FY, 2025) | Gross profit N/A | Gross profit ¥852.5m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income $1.4b (FY, 2025) | Net income N/A | Net income ¥258.9m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 456.6k | Total funding raised $ 358m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |

Teva Pharmaceuticals is a global pharmaceutical company.
View company
LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
View company
Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics.
View company